Target-Based Virtual Screening of Natural Compounds Identifies a Potent Antimalarial With Selective Falcipain-2 Inhibitory Activity

Overview

Journal Front Pharmacol

Date 2022 Apr 25

PMID 35462917

Authors

Amad Uddin

Sonal Gupta

Taj Mohammad

Diksha Shahi

Afzal Hussain

Mohamed F Alajmi

Hesham R El-Seedi

Imtaiyaz Hassan

Shailja Singh

Mohammad Abid

Affiliations

Soon will be listed here.

Abstract

We employed a comprehensive approach of target-based virtual high-throughput screening to find potential hits from the ZINC database of natural compounds against cysteine proteases falcipain-2 and falcipain-3 (FP2 and FP3). Molecular docking studies showed the initial hits showing high binding affinity and specificity toward FP2 were selected. Furthermore, the enzyme inhibition and surface plasmon resonance assays were performed which resulted in a compound ZINC12900664 (ST72) with potent inhibitory effects on purified FP2. ST72 exhibited strong growth inhibition of chloroquine-sensitive (3D7; EC = 2.8 µM) and chloroquine-resistant (RKL-9; EC = 6.7 µM) strains of . Stage-specific inhibition assays revealed a delayed and growth defect during parasite growth and development in parasites treated with ST72. Furthermore, ST72 significantly reduced parasite load and increased host survival in a murine model infected with ANKA. No Evans blue staining in ST72 treatment indicated that ST72 mediated protection of blood-brain barrier integrity in mice infected with . ST72 did not show any significant hemolysis or cytotoxicity against human HepG2 cells suggesting a good safety profile. Importantly, ST72 with CQ resulted in improved growth inhibitory activity than individual drugs in both and studies.

Citing Articles

Model-based fed-batch cultivation of plant cells exhibiting antimalarial and anticancer activity.

Babu R, Veeramani M, Aadinath W, Muthuvijayan V, Singh S, Srivastava S Front Bioeng Biotechnol. 2025; 13:1528570.

PMID: 39944222 PMC: 11815595. DOI: 10.3389/fbioe.2025.1528570.

CACTI: an in silico chemical analysis tool through the integration of chemogenomic data and clustering analysis.

Godinez-Macias K, Winzeler E J Cheminform. 2024; 16(1):84.

PMID: 39049122 PMC: 11270953. DOI: 10.1186/s13321-024-00885-2.

A Comprehensive Multispectroscopic and Computational Analysis of the Interaction between Plant-Based Antiplasmodial Compounds and Bovine Serum Albumin.

Azeem K, Thaer Abdulhameed H, Hussain A, Amir S, Parveen M, Patel R ACS Omega. 2024; 9(5):5576-5591.

PMID: 38343956 PMC: 10851409. DOI: 10.1021/acsomega.3c07630.

Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?.

Gonzalez J, Salas-Sarduy E, Alvarez L, Valiente P, Arni R, Pascutti P Curr Med Chem. 2023; 31(16):2234-2263.

PMID: 37711130 DOI: 10.2174/0929867331666230913165219.

Antimalarial drug discovery: progress and approaches.

Siqueira-Neto J, Wicht K, Chibale K, Burrows J, Fidock D, Winzeler E Nat Rev Drug Discov. 2023; 22(10):807-826.

PMID: 37652975 PMC: 10543600. DOI: 10.1038/s41573-023-00772-9.

References

Singh V, Hada R, Uddin A, Aneja B, Abid M, Pandey K . Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids. Curr Top Med Chem. 2020; 20(5):377-389. DOI: 10.2174/1568026620666200130162347. View

Wang L, Zhang S, Zhu J, Zhu L, Liu X, Shan L . Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening. Bioorg Med Chem Lett. 2014; 24(5):1261-4. DOI: 10.1016/j.bmcl.2014.01.074. View

Francis S, Sullivan Jr D, Goldberg D . Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol. 1997; 51:97-123. DOI: 10.1146/annurev.micro.51.1.97. View

Lipinski C . Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2001; 44(1):235-49. DOI: 10.1016/s1056-8719(00)00107-6. View

Rosenthal P . Antimalarial drug discovery: old and new approaches. J Exp Biol. 2003; 206(Pt 21):3735-44. DOI: 10.1242/jeb.00589. View

Mao J, Luo Q, Zhang H, Zheng X, Shen C, Qi H . Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation. Chem Biol Interact. 2021; 352:109784. DOI: 10.1016/j.cbi.2021.109784. View

Rajguru T, Bora D, Modi M . Combined CADD and Virtual Screening to Identify Novel Nonpeptidic Falcipain-2 Inhibitors. Curr Comput Aided Drug Des. 2020; 17(4):579-588. DOI: 10.2174/1573409916666200701213526. View

Marco M, Coteron J . Falcipain inhibition as a promising antimalarial target. Curr Top Med Chem. 2012; 12(5):408-44. DOI: 10.2174/156802612799362913. View

Melo P, Maluf S, Azevedo M, Paschoalin T, Budu A, Bagnaresi P . Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4. Parasitol Int. 2017; 67(2):233-236. DOI: 10.1016/j.parint.2017.12.005. View

10.

Huy N, Kamei K, Yamamoto T, Kondo Y, Kanaori K, Takano R . Clotrimazole binds to heme and enhances heme-dependent hemolysis: proposed antimalarial mechanism of clotrimazole. J Biol Chem. 2001; 277(6):4152-8. DOI: 10.1074/jbc.M107285200. View

11.

Kumar B, Mohammad T, Amaduddin , Hussain A, Islam A, Ahmad F . Targeting metacaspase-3 from towards antimalarial therapy: A combined approach of and investigation. J Biomol Struct Dyn. 2020; 39(2):421-430. DOI: 10.1080/07391102.2019.1711194. View

12.

Ai H, Chen W, Zhang L, Huang L, Yin Z, Hu H . Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints. Toxicol Sci. 2018; 165(1):100-107. DOI: 10.1093/toxsci/kfy121. View

13.

Basir R, Rahiman S, Hasballah K, Chong W, Talib H, Yam M . Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iran J Parasitol. 2013; 7(4):62-74. PMC: 3537477. View

14.

Lima M, Melo-Filho C, Cassiano G, Neves B, Alves V, Braga R . QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities. Front Pharmacol. 2018; 9:146. PMC: 5845645. DOI: 10.3389/fphar.2018.00146. View

15.

Li H, Huang J, Chen L, Liu X, Chen T, Zhu J . Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening. J Med Chem. 2009; 52(15):4936-40. DOI: 10.1021/jm801622x. View

16.

Kumar A, Dasaradhi P, Chauhan V, Malhotra P . Exploring the role of putative active site amino acids and pro-region motif of recombinant falcipain-2: a principal hemoglobinase of Plasmodium falciparum. Biochem Biophys Res Commun. 2004; 317(1):38-45. DOI: 10.1016/j.bbrc.2004.02.177. View

17.

Lehmann C, Heitmann A, Mishra S, Burda P, Singer M, Prado M . A cysteine protease inhibitor of plasmodium berghei is essential for exo-erythrocytic development. PLoS Pathog. 2014; 10(8):e1004336. PMC: 4148452. DOI: 10.1371/journal.ppat.1004336. View

18.

Nsanzabana C . Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!. Trop Med Infect Dis. 2019; 4(1). PMC: 6473515. DOI: 10.3390/tropicalmed4010026. View

19.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

20.

Singh A, Kalamuddin M, Maqbool M, Mohmmed A, Malhotra P, Hoda N . Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies. Bioorg Chem. 2020; 108:104514. DOI: 10.1016/j.bioorg.2020.104514. View